{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:39:07Z","timestamp":1792024747271,"version":"4.4.0"},"reference-count":111,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: Infertility is a highly meaningful issue with potentially life-changing consequences, and its incidence has been growing worldwide. Assisted reproductive technology (ART) has made giant strides in terms of treating many infertility conditions, despite the risk of developing ovarian hyperstimulation syndrome (OHSS), a potentially life-threatening complication. Methods: This narrative review draws upon scientific articles found in the PubMed database. The search spanned the 1990\u20132024 period. Search strings used included \u201cOHSS\u201d or \u201covarian hyperstimulation\u201d and \u201cIVF\u201d and \u201cGnRH\u201d and \u201chCG\u201d; 1098 results were retrieved and were ultimately narrowed down to 111 suitable sources, i.e., relevant articles dealing with the condition\u2019s underlying dynamics, management pathways, and evidence-based criteria and guidelines, crucial both from a clinical perspective and from the standpoint of medicolegal tenability. Results: The following features constitute OHSS risk factors: young age, low body weight, and polycystic ovarian syndrome (PCOS), among others. GnRH antagonist can substantially lower the risk of severe OHSS, compared to the long protocol with a gonadotropin-releasing hormone (GnRH) agonist. However, a mild or moderate form of OHSS is also possible if the antagonist protocol is used, especially when hCG is used for the final maturation of oocytes. For women at risk of OHSS, GnRH agonist trigger and the freeze-all strategy is advisable. OHSS is one of the most frequent complications, with a 30% rate in IVF cycles. Conclusion: Providing effective care for OHSS patients begins with early diagnosis, while also evaluating for comorbidities and complications. In addition to that, we should pay more attention to the psychological component of this complication and of infertility as a whole. Compliance with guidelines and evidence-based best practices is essential for medicolegal tenability.<\/jats:p>","DOI":"10.3390\/jpm14090915","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:54:10Z","timestamp":1724846050000},"page":"915","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-4269","authenticated-orcid":false,"given":"Giuseppe","family":"Gullo","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, IVF Unit, University of Palermo, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Cucinella","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, IVF Unit, University of Palermo, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8121-9845","authenticated-orcid":false,"given":"Vukasin","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Emergency Medicine Center of Montenegro, Faculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Stojkovic","sequence":"additional","affiliation":[{"name":"Clinic of Endocrinology, Diabetes and Metabolic Disorders, University Clinical Center of Serbia, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-0238","authenticated-orcid":false,"given":"Carmine","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Medicine and Translational Surgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"},{"name":"Istituto Dermopatico dell\u2019Immacolata (IDI IRCCS), 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Vita","family":"Streva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, IVF Unit, University of Palermo, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1041-3189","authenticated-orcid":false,"given":"Alessandra","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, IVF Unit, University of Palermo, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Perino","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, IVF Unit, University of Palermo, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Marinelli","sequence":"additional","affiliation":[{"name":"School of Law, Polytechnic University of Marche, 60121 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dem046","article-title":"International Estimates of Infertility Prevalence and Treatment-Seeking: Potential Need and Demand for Infertility Medical Care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-7954-10-17","article-title":"Measuring Infertility in Populations: Constructing a Standard Definition for Use with Demographic and Reproductive Health Surveys","volume":"10","author":"Mascarenhas","year":"2012","journal-title":"Popul. Health Metr."},{"key":"ref_3","first-page":"211","article-title":"Systematic Review of Data Concerning Etiopathology of Ovarian Hyperstimulation Syndrome","volume":"47","author":"Delvigne","year":"2002","journal-title":"Int. J. Fertil. Womens Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00006254-199807000-00024","article-title":"Ovarian Hyperstimulation Syndrome: Facts and Fallacies","volume":"53","author":"Beerendonk","year":"1998","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humrep\/deh124","article-title":"New Insights into the Pathophysiology of Ovarian Hyperstimulation Syndrome. What Makes the Difference between Spontaneous and Iatrogenic Syndrome?","volume":"19","author":"Delbaere","year":"2004","journal-title":"Hum. Reprod."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0015-0282(00)00628-2","article-title":"A Case of Spontaneous Ovarian Hyperstimulation Syndrome with a Potential Mutation in the hCG\/LH Receptor Gene","volume":"74","author":"Akerman","year":"2000","journal-title":"Fertil. Steril."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/09513590.2019.1592153","article-title":"Ovarian Hyperstimulation Syndrome. A New Look at an Old Problem","volume":"35","author":"Petrenko","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian Hyperstimulation Syndrome: Classifications and Critical Analysis of Preventive Measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and Prevention of Ovarian Hyperstimulation Syndrome (OHSS): A Review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/humupd\/8.3.291","article-title":"A Qualitative Systematic Review of Coasting, a Procedure to Avoid Ovarian Hyperstimulation Syndrome in IVF Patients","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of Clinical Course and Treatment of Ovarian Hyperstimulation Syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"The Practice Committee of the American Society for Reproductive Medicine (2004). Ovarian Hyperstimulation Syndrome. Fertil. Steril., 82, 81\u201386.","DOI":"10.1016\/j.fertnstert.2004.05.005"},{"key":"ref_13","unstructured":"Hugh, T., Lubna, P., and Emre, S. (2020). Speroff\u2019s Clinical Gynecologic Endocrinology and Infertility, Wolters Kluwer, Lippincott Williams & Wilkins. [9th ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Medenica, S., Zivanovic, D., Batkoska, L., Marinelli, S., Basile, G., Perino, A., Cucinella, G., Gullo, G., and Zaami, S. (2022). The Future Is Coming: Artificial Intelligence in the Treatment of Infertility Could Improve Assisted Reproduction Outcomes\u2014The Value of Regulatory Frameworks. Diagnostics, 12.","DOI":"10.3390\/diagnostics12122979"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"dead093.014","DOI":"10.1093\/humrep\/dead093.186","article-title":"O-153 Assisted Reproductive Technology (ART) in Europe 2020 and Development of a Strategy of Vigilance: Preliminary Results Generated from European Registers by the ESHRE EIM Consortium","volume":"38","author":"Smeenk","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_16","unstructured":"Centers for Disease Control and Prevention (2022). 2020 Assisted Reproductive Technology Fertility Clinic and National Summary Report, US Department of Health and Human Services."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/humrep\/deab198","article-title":"International Committee for Monitoring Assisted Reproductive Technologies World Report: Assisted Reproductive Technology, 2014","volume":"36","author":"Chambers","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)56101-9","article-title":"Natural Cycle In Vitro Fertilization-Embryo Transfer at the University of Ottawa: An Inefficient Therapy for Tubal Infertility","volume":"60","author":"Claman","year":"1993","journal-title":"Fertil. Steril."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/humrep\/16.4.696","article-title":"A Randomized Study Comparing IVF in the Unstimulated Cycle with IVF Following Clomiphene Citrate","volume":"16","author":"Ingerslev","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr. Rev."},{"key":"ref_21","first-page":"CD009577","article-title":"Long-Acting FSH versus Daily FSH for Women Undergoing Assisted Reproduction","volume":"2016","author":"Pouwer","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e260512","DOI":"10.1136\/bcr-2024-260512","article-title":"Ovarian Hyperstimulation Syndrome without Gonadotropin Stimulation: An Unusual Response to a GnRH Agonist","volume":"17","author":"Petch","year":"2024","journal-title":"BMJ Case Rep."},{"key":"ref_23","unstructured":"Strauss, J.F., and Barbieri, R.L. (2019). Yen & Jaffe\u2019s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, Elsevier. [8th ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2007.02.011","article-title":"A Quantitative Assessment of Follicle Size on Oocyte Developmental Competence","volume":"90","author":"Rosen","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_25","first-page":"CD003719","article-title":"Recombinant versus Urinary Human Chorionic Gonadotrophin for Final Oocyte Maturation Triggering in IVF and ICSI Cycles","volume":"2016","author":"Youssef","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","first-page":"160","article-title":"Cumulative live birth rates per oocytes retrieved cycle: Evaluation of clinical outcomes of IVF\/ICSI","volume":"53","author":"Wu","year":"2018","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref_27","first-page":"e42303","article-title":"Pregnancy Outcomes of Assisted Reproductive Technology (ART) Cycle Complicated by Ovarian Hyperstimulation Syndrome (OHSS): Case Series Study","volume":"15","author":"Alfaraj","year":"2023","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01204048","article-title":"Ovarian Hyperstimulation Syndrome: A Review of Pathophysiology","volume":"9","author":"Bergh","year":"1992","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0015-0282(16)57353-1","article-title":"Increased Capillary Permeability Induced by Human Follicular Fluid: A Hypothesis for an Ovarian Origin of the Hyperstimulation Syndrome","volume":"63","author":"Goldsman","year":"1995","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0002-9378(90)90428-A","article-title":"Transcapillary Fluid Dynamics during Ovarian Stimulation for in Vitro Fertilization","volume":"162","author":"Tollan","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/14647273.2013.788313","article-title":"Management of Ovarian Hyperstimulation Syndrome. Produced on Behalf of the BFS Policy and Practice Committee","volume":"16","author":"Tan","year":"2013","journal-title":"Hum. Fertil."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14647270601111239","article-title":"Review of the Evidence Base of Strategies to Prevent Ovarian Hyperstimulation Syndrome","volume":"10","author":"Mathur","year":"2007","journal-title":"Hum. Fertil."},{"key":"ref_33","first-page":"1967","article-title":"Human Chorionic Gonadotropin-Dependent Expression of Vascular Endothelial Growth Factor\/Vascular Permeability Factor in Human Granulosa Cells: Importance in Ovarian Hyperstimulation Syndrome","volume":"80","author":"Neulen","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of Vascular Permeability by Vascular Endothelial Growth Factors","volume":"39","author":"Bates","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI4814","article-title":"Role of Vascular Endothelial Cell Growth Factor in Ovarian Hyperstimulation Syndrome","volume":"102","author":"Levin","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/16.1.24","article-title":"Prevention of Severe Ovarian Hyperstimulation Syndrome in IVF with or without ICSI and Embryo Transfer: A Modified \u2018coasting\u2019 Strategy Based on Ultrasound for Identification of High-Risk Patients","volume":"16","author":"Zosmer","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_37","unstructured":"(2011). Gonadotropin-Releasing Hormone Agonist versus HCG for Oocyte Triggering in Antagonist Assisted Reproductive Technology Cycles. Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(00)00670-1","article-title":"Role of Vascular Endothelial Growth Factor in Ovarian Physiology and Pathology","volume":"74","author":"Geva","year":"2000","journal-title":"Fertil. Steril."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/tog.12037_10","article-title":"Re: Ovarian Hyperstimulation Syndrome (OHSS)","volume":"15","author":"Sivanesan","year":"2013","journal-title":"Obstet. Gynaecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rbmo.2012.01.005","article-title":"Comparative Incidence of Ovarian Hyperstimulation Syndrome Following Ovarian Stimulation with Corifollitropin Alfa or Recombinant FSH","volume":"24","author":"Tarlatzis","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1679-45082016RC3429","article-title":"Ovarian Hyperstimulation Syndrome in a Spontaneous Singleton Pregnancy","volume":"14","author":"Cabar","year":"2016","journal-title":"Einstein"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/FPC.0000000000000374","article-title":"The N680S Variant in the Follicle-Stimulating Hormone Receptor Gene Identifies Hyperresponders to Controlled Ovarian Stimulation","volume":"29","author":"Nenonen","year":"2019","journal-title":"Pharmacogenetics Genom."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jc.2005-1580","article-title":"Presence and Absence of Follicle-Stimulating Hormone Receptor Mutations Provide Some Insights into Spontaneous Ovarian Hyperstimulation Syndrome Physiopathology","volume":"91","author":"Montanelli","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","first-page":"6809","article-title":"Fresh vs. Frozen Embryo Transfer in Assisted Reproductive Techniques: A Single Center Retrospective Cohort Study and Ethical-Legal Implications","volume":"27","author":"Gullo","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_45","first-page":"3537","article-title":"Elective Egg Freezing: Can You Really Turn Back the Clock?","volume":"19","author":"Zaami","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2014.05.008","article-title":"GnRHa Trigger for Final Oocyte Maturation: Is HCG Trigger History?","volume":"29","author":"Humaidan","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gullo, G., Scaglione, M., Cucinella, G., Chiantera, V., Perino, A., Greco, M.E., Lagan\u00e0, A.S., Marinelli, E., Basile, G., and Zaami, S. (2022). Neonatal Outcomes and Long-Term Follow-Up of Children Born from Frozen Embryo, a Narrative Review of Latest Research Findings. Medicina, 58.","DOI":"10.3390\/medicina58091218"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0015-0282(98)00528-7","article-title":"Pulmonary Manifestations of Severe Ovarian Hyperstimulation Syndrome: A Multicenter Study","volume":"71","author":"Abramov","year":"1999","journal-title":"Fertil. Steril."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.fertnstert.2010.12.015","article-title":"Obstetric Outcome of Women with In Vitro Fertilization Pregnancies Hospitalized for Ovarian Hyperstimulation Syndrome: A Case-Control Study","volume":"95","author":"Courbiere","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2014.04.015","article-title":"Is Severe OHSS Associated with Adverse Pregnancy Outcomes? Evidence from a Case\u2013Control Study","volume":"29","author":"Haas","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"ref_51","first-page":"1469","article-title":"Directed Calf Raising in the Conditions of Adaptive Technology","volume":"76","author":"Baimukanov","year":"2021","journal-title":"Arch. Razi Inst."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12978-015-0053-4","article-title":"Optimal Cutoff Value of Basal Anti-Mullerian Hormone in Iranian Infertile Women for Prediction of Ovarian Hyper-Stimulation Syndrome and Poor Response to Stimulation","volume":"12","author":"Aghssa","year":"2015","journal-title":"Reprod. Health"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13048-021-00773-5","article-title":"Low Risk of OHSS with Follitropin Delta Use in Women with Different Polycystic Ovary Syndrome Phenotypes: A Retrospective Case Series","volume":"14","author":"Yacoub","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sun, B., Ma, Y., Li, L., Hu, L., Wang, F., Zhang, Y., Dai, S., and Sun, Y. (2020). Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF\/ICSI. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.615957"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2024). Prevention of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline. Fertil. Steril., 121, 230\u2013245.","DOI":"10.1016\/j.fertnstert.2023.11.013"},{"key":"ref_56","first-page":"248","article-title":"Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management","volume":"43","author":"Parsanezhad","year":"2018","journal-title":"Iran. J. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The Role of Vascular Endothelial Growth Factor and Interleukins in the Pathogenesis of Severe Ovarian Hyperstimulation Syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum. Reprod. Update"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/humrep\/der349","article-title":"Ovarian Hyperstimulation Syndrome Is Correlated with a Reduction of Soluble VEGF Receptor Protein Level and a Higher Amount of VEGF-A","volume":"27","author":"Pietrowski","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_59","first-page":"48","article-title":"Cabergoline for Reducing Ovarian Hyperstimulation Syndrome in Assisted Reproductive Technology Treatment Cycles. A Prospective Randomized Controlled Trial","volume":"60","author":"Amir","year":"2015","journal-title":"J. Reprod. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.rbmo.2013.03.002","article-title":"Clinical Outcome According to Timing of Cabergoline Initiation for Prevention of OHSS: A Randomized Controlled Trial","volume":"26","author":"Seow","year":"2013","journal-title":"Reprod. Biomed. Online"},{"key":"ref_61","first-page":"CD012693","article-title":"Individualised Gonadotropin Dose Selection Using Markers of Ovarian Reserve for Women Undergoing In Vitro Fertilisation plus Intracytoplasmic Sperm Injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/REP-17-0268","article-title":"Kisspeptin-10 Inhibits OHSS by Suppressing VEGF Secretion","volume":"154","author":"Zhai","year":"2017","journal-title":"Reproduction"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Papanikolaou, E.G., Polyzos, N.P., Humaidan, P., Pados, G., Bosch, E., Tournaye, H., and Tarlatzis, B. (2011). Aromatase Inhibitors in Stimulated IVF Cycles. Reprod. Biol. Endocrinol., 9.","DOI":"10.1186\/1477-7827-9-85"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"386","DOI":"10.52547\/rbmb.11.3.386","article-title":"Evaluation of The Effect of Letrozole in the Ovarian Hyperstimulation Syndrome Prevention in Participants at Risk of Treatment with Ovulation-Stimulating Drugs:A Randomized Controlled Trial","volume":"11","author":"Aasasi","year":"2022","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.21037\/apm-21-1699","article-title":"Prednisone Combined with Letrozole Reduced Risk of Ovarian Hyperstimulation Syndrome (OHSS) in Women Undergoing Long-Term Gonadotropin-Releasing Hormone Analog Treatment","volume":"10","author":"Fang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12978-020-01042-2","article-title":"Whether Letrozole Could Reduce the Incidence of Early Ovary Hyperstimulation Syndrome after Assisted Reproductive Technology? A Systematic Review and Meta-Analysis","volume":"17","author":"Zhao","year":"2020","journal-title":"Reprod. Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/deg451","article-title":"Intravenous Albumin Does Not Prevent Moderate-Severe Ovarian Hyperstimulation Syndrome in High-Risk IVF Patients: A Randomized Controlled Study","volume":"18","author":"Bellver","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/humrep\/16.9.1880","article-title":"The Questionable Use of Albumin for the Prevention of Ovarian Hyperstimulation Syndrome in an IVF Programme: A Randomized Placebo-Controlled Trial","volume":"16","author":"Gal","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.fertnstert.2010.05.026","article-title":"Intravenous Albumin Administration for the Prevention of Severe Ovarian Hyperstimulation Syndrome: A Systematic Review and Metaanalysis","volume":"95","author":"Venetis","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_70","first-page":"CD001302","article-title":"Volume Expanders for the Prevention of Ovarian Hyperstimulation Syndrome","volume":"2016","author":"Youssef","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.fertnstert.2008.09.011","article-title":"Patients with Severe Ovarian Hyperstimulation Syndrome Can Be Managed Safely with Aggressive Outpatient Transvaginal Paracentesis","volume":"92","author":"Smith","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_72","first-page":"1","article-title":"A programme of outpatient surveillance for women at risk of severe OHSS following IVF:a prospective follow-up review of 99 cases","volume":"14","author":"Shukla","year":"2011","journal-title":"Hum. Fertil."},{"key":"ref_73","unstructured":"Hamoda, H., Drakeley, A.J., Brian, K., Evbuomwan, I.O., Mathur, R., and On behalf of the Royal College of 7 Obstetricians and Gynaecologists (2024). Green-Top Guideline No. 5\u2014The Management of Ovarian Hyperstimulation Syndrome, Royal College of Obstetricians and Gynaecologists."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kamath, M.S., Maheshwari, A., Bhattacharya, S., Lor, K.Y., and Gibreel, A. (2017). Oral Medications Including Clomiphene Citrate or Aromatase Inhibitors with Gonadotropins for Controlled Ovarian Stimulation in Women Undergoing In Vitro Fertilisation. Cochrane Database Syst. Rev., CD008528.","DOI":"10.1002\/14651858.CD008528.pub3"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/19396368.2014.957879","article-title":"Effects of Different Doses of Letrozole on the Incidence of Early-Onset Ovarian Hyperstimulation Syndrome after Oocyte Retrieval","volume":"60","author":"He","year":"2014","journal-title":"Syst. Biol. Reprod. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Di Guardo, F., Lello, C., Incognito, G.G., Bruno, M.T., and Palumbo, M. (2023). Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy. J. Clin. Med., 12.","DOI":"10.3390\/jcm12020614"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01443615.2020.1870944","article-title":"Cabergoline versus Calcium Infusion in the Prevention of Ovarian Hyperstimulation Syndrome: A Randomised Controlled Study","volume":"42","author":"Fouda","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2024.07.054","article-title":"Calcium versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome: A Systematic Review and Meta-Analysis","volume":"301","author":"Baradwan","year":"2024","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_79","first-page":"1248","article-title":"Calcium Gluconate Infusion Is Not as Effective as Dopamine Agonists in Preventing Ovarian Hyperstimulation Syndrome","volume":"26","author":"Turktekin","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_80","first-page":"CD008605","article-title":"Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome","volume":"4","author":"Tang","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kadoura, S., Alhalabi, M., and Nattouf, A.H. (2022). Conventional GnRH Antagonist Protocols versus Long GnRH Agonist Protocol in IVF\/ICSI Cycles of Polycystic Ovary Syndrome Women: A Systematic Review and Meta-Analysis. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-08400-z"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10815-014-0253-9","article-title":"Prolonged Gonadotropin Stimulation for Assisted Reproductive Technology Cycles Is Associated with Decreased Pregnancy Rates for All Women except for Women with Polycystic Ovary Syndrome","volume":"31","author":"Ryan","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_83","first-page":"833","article-title":"Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome","volume":"48","author":"Zhu","year":"2013","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2009.05.092","article-title":"Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) and Its Effect on Assisted Reproductive Technology (ART) Treatment and Outcome","volume":"94","author":"Luke","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.08.037","article-title":"Low-Dose Acetylsalicylic Acid plus Prednisolone as an Adjuvant Treatment in IVF: A Prospective, Randomized Study","volume":"90","author":"Revelli","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Wu, D., Shi, H., Yu, Y., Yu, T., and Zhai, J. (2022). Comparison of the Effectiveness of Various Medicines in the Prevention of Ovarian Hyperstimulation Syndrome: A Network Meta-Analysis of Randomized Controlled Trials. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.808517"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/RD9.0000000000000058","article-title":"Peripheral Blood Transcriptome Analysis of Patients with Ovarian Hyperstimulation Syndrome through High-Throughput Sequencing","volume":"7","author":"Yan","year":"2023","journal-title":"Reprod. Dev. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1007\/s43032-023-01252-6","article-title":"Assisted Reproductive Techniques and Risk of Congenital Heart Diseases in Children: A Systematic Review and Meta-Analysis","volume":"30","author":"Gullo","year":"2023","journal-title":"Reprod. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1080\/01443615.2022.2109953","article-title":"Impact of Assisted Reproduction Techniques on the Neuro-Psycho-Motor Outcome of Newborns: A Critical Appraisal","volume":"42","author":"Gullo","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_90","first-page":"47","article-title":"Psychological Variables in Medically Assisted Reproduction: A Systematic Review","volume":"21","author":"Burgio","year":"2022","journal-title":"Przegl\u0105d Menopauzalny"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.curobgyn.2005.01.003","article-title":"Prevention and Management of Ovarian Hyperstimulation Syndrome","volume":"15","author":"Mathur","year":"2005","journal-title":"Curr. Obstet. Gynaecol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.fertnstert.2011.06.020","article-title":"Thyroid Function during Ovarian Stimulation: A Systematic Review","volume":"96","author":"Mintziori","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bmj.296.6616.171","article-title":"Hyperthyroidism after Gonadotrophic Ovarian Stimulation","volume":"296","author":"Noppen","year":"1988","journal-title":"BMJ"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s10815-021-02206-0","article-title":"Changes in Thyroid Function during Controlled Ovarian Hyperstimulation (COH) and Its Impact on Assisted Reproduction Technology (ART) Outcomes: A Systematic Review and Meta-Analysis","volume":"38","author":"Li","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e2011995","DOI":"10.1001\/jamanetworkopen.2020.11995","article-title":"Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization: A Systematic Review and Meta-Analysis","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000512790","article-title":"2021 European Thyroid Association Guideline on Thyroid Disorders Prior to and during Assisted Reproduction","volume":"9","author":"Poppe","year":"2020","journal-title":"Eur. Thyroid. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2484\/rcr.v10i1.1050","article-title":"Spontaneous Ovarian Hyperstimulation Syndrome with Primary Hypothyroidism: Imaging a Rare Entity","volume":"10","author":"Ilanchezhian","year":"2015","journal-title":"Radiol. Case Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1023\/A:1026543027300","article-title":"Case Report: Ovarian Hyperstimulation Syndrome Complicating a Spontaneous Singleton Pregnancy: A Case Report","volume":"18","author":"Chae","year":"2001","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and Treatment of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline","volume":"106","author":"Pfeifer","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_100","unstructured":"Ovarian Stimulation for IVF\/ICSI (2023, October 10). Guideline of the European Society of Human Reproduction and Embryology. Issued in October 2019 by the ESHRE Reproductive Endocrinology Guideline Group., Available online: https:\/\/www.eshre.eu\/Guidelines-and-Legal\/Guidelines\/Ovarian-Stimulation-in-IVF-ICSI."},{"key":"ref_101","unstructured":"Royal College of Obstetricians and Gynaecologists.The Management of Ovarian Hyperstimulation Syndrome (2023, October 10). Green-Top Guideline No. 5. Issued in February 2016. Available online: https:\/\/www.rcog.org.uk\/media\/or1jqxbf\/gtg_5_ohss.pdf."},{"key":"ref_102","first-page":"82","article-title":"Guidelines and Best Practices: Remarks on the Gelli-Bianco Law","volume":"169","author":"Zaami","year":"2018","journal-title":"Clin. Ter."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/19396368.2020.1855271","article-title":"COVID-19 and Human Reproduction: A Pandemic That Packs a Serious Punch","volume":"67","author":"Anifandis","year":"2021","journal-title":"Syst. Biol. Reprod. Med."},{"key":"ref_104","unstructured":"Rallo, G., Negro, F., Consalvo, F., Piersanti, V., and Marinelli, S. (2021). Medically Assisted Procreation in Times of COVID-19: What Impact on Health Care System Organization and the Reproductive Rights of Couples?. Acta Biomed., 92."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Tran, H.P., Nguyen, N.N., Ho, N.-T., Tran, T.T.-T., Ly, L.T., Hoang, T.T.-D., Le, D.T.-P., Tzeng, C.-R., Vo, V.T., and Tran, L.-G. (2024). The Impacts of Telemedicine on Assisted Reproduction: A Systematic Review and Meta-Analysis. Reprod. Biomed. Online, 48.","DOI":"10.1016\/j.rbmo.2023.103752"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Marinelli, S., Basile, G., and Zaami, S. (2022). Telemedicine, Telepsychiatry and COVID-19 Pandemic: Future Prospects for Global Health. Healthcare, 10.","DOI":"10.3390\/healthcare10102085"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13625187.2022.2045936","article-title":"Fertility Preservation in Female Cancer Sufferers: (Only) a Moral Obligation?","volume":"27","author":"Zaami","year":"2022","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Bergamin, E., Fiorillo, A., Grassi, V.M., Lodise, M., Vetrugno, G., and De-Giorgio, F. (2023). Medical Professional Liability in Obstetrics and Gynecology: A Pilot Study of Criminal Proceedings in the Public Prosecutor\u2019s Office at the Court of Rome. Healthcare, 11.","DOI":"10.3390\/healthcare11091331"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1389201015666140430101639","article-title":"Amniotic Fluid Embolism: What Level of Scientific Evidence Can Be Drawn? A Systematic Review","volume":"14","author":"Frati","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41574-021-00604-z","article-title":"Assessment and Treatment of Thyroid Disorders in Pregnancy and the Postpartum Period","volume":"18","author":"Lee","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13048-024-01406-3","article-title":"Ovarian Hyperstimulation Syndrome Combined with Hypothyroidism: A Comprehensive Review","volume":"17","author":"Zhou","year":"2024","journal-title":"J. Ovarian Res."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/9\/915\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:44:30Z","timestamp":1760111070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/9\/915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":111,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["jpm14090915"],"URL":"https:\/\/doi.org\/10.3390\/jpm14090915","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]}}}